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Abstract
Microbial populations often contain a fraction of slow-growing persister cells that
withstand antibiotics and other stress factors. Current theoretical models predict that
persistence levels should reflect a stable state in which the survival advantage of per-
sisters under adverse conditions is balanced with the direct growth cost impaired
under favourable growth conditions, caused by the nonreplication of persister cells.
Based on this direct growth cost alone, however, it remains challenging to explain the
observed low levels of persistence (<<1%) seen in the populations of many species.
Here, we present data from the opportunistic human pathogen Pseudomonas aerugin-
osa that can explain this discrepancy by revealing various previously unknown costs
of persistence. In particular, we show that in the absence of antibiotic stress, increased
persistence is traded off against a lengthened lag phase as well as a reduced survival
ability during stationary phase. We argue that these pleiotropic costs contribute to the
very low proportions of persister cells observed among natural P. aeruginosa isolates
(3 3 108–3 3 104) and that they can explain why strains with higher proportions of
persister cells lose out very quickly in competition assays under favourable growth
conditions, despite a negligible difference in maximal growth rate. We discuss how
incorporating these trade-offs could lead to models that can better explain the evolu-
tion of persistence in nature and facilitate the rational design of alternative therapeutic
strategies for treating infectious diseases.
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Introduction
Development of antibiotic resistance in bacteria poses a
serious threat to both human and animal health (Bush
et al. 2011). Apart from genetic adaptation, however,
additional mechanisms enable micro-organisms to tran-
siently tolerate antibiotics (Stewart 2002; Fux et al. 2005;
Levin & Rozen 2006; Dhar & McKinney 2007). One such
mechanism is known as persistence and involves a
small fraction of cells making a phenotypic switch to a
quiescent state. This switch results in slow or zero
growth and confers tolerance to high doses of antibiot-
ics (Balaban et al. 2004; Keren et al. 2004; Levin & Rozen
2006; Gefen & Balaban 2009; Kint et al. 2012; Maison-
neuve & Gerdes 2014). In contrast to resistance, antibi-
otic tolerance of persister cells is a reversible,
noninherited phenotype. Consequently, following
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antibiotic treatment, the surviving persisters resume
growth and give rise to a new population that is as sen-
sitive to antibiotics as the ancestral population (Keren
et al. 2004; Levin & Rozen 2006; Lewis 2007).
Persistence is of great medical importance, as it occurs
in numerous pathogens, including Acinetobacter bauman-
nii, Burkholderia cepacia, Escherichia coli, Listeria monocyt-
ogenes, Mycobacterium tuberculosis, Pseudomonas
aeruginosa, Salmonella enterica, Staphylococcus aureus and
Streptococcus suis (Willenborg et al. 2014) (Stewart et al.
2003; Levin & Rozen 2006; Dhar & McKinney 2007;
Lewis 2010; Fauvart et al. 2011; Barth et al. 2013; Knud-
sen et al. 2013; Slattery et al. 2013; Van Acker et al. 2013;
Maisonneuve & Gerdes 2014; Willenborg et al. 2014). In
addition, persistence has been identified as a key cause
of failure of antibiotic treatments, particularly in recalci-
trant chronic infections (LaFleur et al. 2010; Lewis 2010;
Mulcahy et al. 2010; Fauvart et al. 2011; Orman & Bry-
nildsen 2013). Given this huge medical importance, the
past decade has seen rapidly growing efforts to unravel
the biology and mechanisms underlying persistence
(Mulcahy et al. 2010; Kint et al. 2012; Stewart & Rozen
2012; Barraud et al. 2013; Hofsteenge et al. 2013; Knud-
sen et al. 2013; Van Acker et al. 2013; Maisonneuve &
Gerdes 2014; Willenborg et al. 2014). Despite this active
ongoing research, many questions remain, particularly
regarding the mechanisms and evolutionary forces that
drive variation in persistence in natural populations
(Balaban et al. 2013). Empirically, it has been observed
that persisters can be formed either by random switch-
ing (Balaban et al. 2004; Keren et al. 2004) or in response
to specific environmental cues (D€orr et al. 2009; Vega
et al. 2012; Maisonneuve & Gerdes 2014). These findings
have inspired several theoretical models aimed at untan-
gling the selective forces that determine the develop-
ment and level of persistence. For example, Kussell &
Leibler (2005) showed that stochastic switching is
favoured most in environments that change relatively
infrequently, whereas responsive switching was found
to be most beneficial in highly unpredictable environ-
ments. Other studies have analysed persistence as a bet-
hedging mechanism, in which bacterial lineages trade
instantaneous growth for long-term survival (Kussell
et al. 2005; Veening et al. 2008). Similar to models
describing dormancy and diapause in plant seeds and
aquatic invertebrates (Cohen 1966; Philippi & Seger
1989; Patra & Klumpp 2013; Baskin & Baskin 2014), these
models of persistence predict that the optimal rate of
entering the persister state should be inversely propor-
tional to the duration of favourable environmental con-
ditions, while the optimal rate of waking-up from the
persister state should be inversely proportional to the
duration of stressful environmental conditions (Lach-
mann & Jablonka 1996; Thattai & van Oudenaarden
2004; Kussell & Leibler 2005; Kussell et al. 2005; Patra &
Klumpp 2013). Similarly, Gardner et al. (2007) predicted
that the unbeatable or ‘evolutionarily stable’ allocation
to persister cells should be inversely proportional to the
interval between antibiotic strikes and argued that the
commonly observed increase in the proportion of per-
sisters under nutrient-limiting conditions (Keren et al.
2004; Moker et al. 2010; Luidalepp et al. 2011; Knudsen
et al. 2013) could be an adaptive strategy to reduce com-
petition among genetically related lineages.
Despite the importance of models of bacterial persis-
tence, few studies have tried to validate such models in
detail. More problematically, there appears to be a large
discrepancy between typical model predictions and
empirical observations, limiting the practical use of
available models. For example, Kussell et al. (2005) cal-
culated that the percentage of persister cells typically
found in E. coli (approximately 0.0001–0.001 %, Lewis
2010) would match optimal switching rates if the bacte-
ria were exposed to antibiotics for just 1 day every
100 years. Clearly, this prediction appears highly unreal-
istic and hints at low levels of persistence being main-
tained by other factors than just a direct growth cost.
Indeed, several studies have hinted at the possibility that
the main cost of persistence might not stem from the
nonreplication of persister cells but rather from fitness
trade-offs with other growth parameters, such as the
length of the lag phase before growth commences upon
new colonizations (Balaban et al. 2004) or survival ability
in resource-deprived environments (Gardner et al. 2007).
In tentative support of this ‘pleiotropic cost’ hypothesis,
it was found that in E. coli, the high-persister mutant
strain hipA7 had an extended lag phase when inoculated
into fresh medium (Balaban et al. 2004; Gefen et al. 2008)
and that wild-type cultures displayed lengthened lag
phases when persistence was increased through starva-
tion (Levin-Reisman et al. 2010; Luidalepp et al. 2011). In
addition, a similar lengthening of the lag phase has been
observed in the high-persister mutant shp in Salmo-
nella enterica (Slattery et al. 2013). The full extent of such
fitness trade-offs and antagonistic pleiotropy, however,
has not been examined in detail, and it remains
unknown whether also in other species, persistence neg-
atively affects other growth parameters.
The aim of the present study was to study the factors
that drive the evolution of persistence in the opportunis-
tic human pathogen P. aeruginosa and document the
pleiotropic costs and fitness trade-offs that could help
explain the observed low levels of persistence (Moker
et al. 2010; Mulcahy et al. 2010; Fauvart et al. 2011). In par-
ticular, we present competition assays among strains and
mutants with variable levels of persisters under contrast-
ing antibiotic treatment schedules (cf. Balaban et al. 2004;
Stewart & Rozen 2012) and provide data on persistence
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levels among 16 environmental and clinical Pseudomonas
isolates. Subsequently, we show that the competitive
advantage of low-persister strains under favourable
growth conditions as well as the extremely low observed
proportions of persistence in natural isolates cannot ade-
quately be explained based on a direct growth cost alone.
Subsequently, this hypothesis is confirmed by experi-
ments that show that increased persistence in P. aerugin-
osa is traded off against a lengthened lag phase under
favourable growth conditions and a reduced survival
ability in resource-deprived environments. We conclude
with a discussion about the impact that our results could
have for the rational design of alternative therapeutic
strategies to treat infectious diseases.
Materials and methods
Strains and culture conditions
We used the representative P. aeruginosa wild-type strain
PA14 (wt) and the isogenic high-persister (hip) mutant
CMPG13407 (De Groote et al. 2009), as well as a natural
low-persister strain Br257 and the high-persister strain
Br642 (Pirnay et al. 2002a). The CMPG13407 hip mutant
has a mutation in pilH, which encodes a CheY-like
response regulator that controls type IV pilus expression,
and produces almost 50 times more persister cells than
the wt (0.03 % in the hip mutant vs. 7 9 104% in the wt,
Table S1, Supporting information; De Groote et al. 2009).
The environmental isolate Br257 and the clinical isolate
Br642 were chosen because they vary almost 200-fold in
their respective proportion of persister cells (1 9 105%
in Br257 vs. 2 9 103% in Br642, Table S1, Supporting
information), but otherwise have similar growth charac-
teristics (i.e. no significant differences in growth rate and
carrying capacity, Fig. S5, Supporting information). Nat-
ural levels of persistence were determined in 16 environ-
mental and clinical isolates of P. aeruginosa (Pirnay et al.
2002a, Table S1, Supporting information).
All strains were cultured in Mueller Hinton Broth
(MHB, BD Difco) at 37 °C, shaking at 200 rpm, unless
stated otherwise. Serial dilutions of samples were pla-
ted on TSB agar plates and incubated at 37 °C for 24 h
to quantify the number of colony-forming units (CFU).
Competition assays between high- and low-persister
strains
To determine whether persistence levels can be inter-
preted as evolutionarily stable strategies that are
attuned to particular frequencies of antibiotic attack
(Kussell et al. 2005; Gardner et al. 2007; Patra & Klumpp
2013), we carried out competition assays between high-
and low-persister strains either in the absence or pres-
ence of periodic antibiotic exposure (Balaban et al. 2004;
Stewart & Rozen 2012). We refer to the latter as fre-
quent antibiotic treatment. The expectation was that in
the absence of antibiotic exposure, the low-persister
strains would win out, whereas the high-persister
strains would do better in its presence (Balaban et al.
2004; Kussell et al. 2005; Stewart & Rozen 2012).
To test this prediction, we compared the growth of
pairs of high- and low-persister strains in competition,
either when they were regrown repeatedly in fresh
medium, or when the strains were intermittently treated
with the fluoroquinolone antibiotic ofloxacin, which is
widely used for the treatment of P. aeruginosa infections
(Mulcahy et al. 2010). Importantly, the high-persister
strains or mutants that we used for these experiments
had much lower absolute proportions of persisters
(0.002% for the high-persister strain Br642 and 0.03%
for the PA14 hip mutant, Table S1, Supporting informa-
tion) than those used in comparable experiments car-
ried out in E. coli (e.g. up to 4% in the competition
assays among three natural pairs of strains carried out
by Stewart & Rozen 2012). This meant that in our
experiments, in contrast to previous studies (Balaban
et al. 2004; Stewart & Rozen 2012), there was a negligi-
bly small direct growth cost due to nonreplication of
persister cells under favourable growth conditions. This
in turn implied that any advantage of low-persister
strains under such conditions was expected to be
caused by the presence of additional, pleiotropic costs
of persistence.
Competition experiments were carried out by first
adjusting overnight cultures of the competing strains to
an optical density of 0.5 at 595 nm (OD595), mixing
equal volumes of both, diluting them 100-fold in
100 mL of fresh medium and growing them together
for 19 h until stationary phase (approximately
5 9 109 CFU per ml). Subsequently, persistence levels
were quantified as described below, using colony mor-
phology after plating to visually distinguish competing
strains, and samples were subjected either to antibiotic
or control treatments, after which 100 mL of fresh med-
ium was re-inoculated via 100- or 100 000-fold dilution,
respectively. These 24-h cycles were repeated five times,
and each treatment combination was replicated at least
three times. In the antibiotic treatment conditions, oflox-
acin was administered for 5 h at approximately 109 the
minimum inhibitory concentration (MIC), which was
5 lg/mL for the wt strain and hip mutant, and 100 lg/
mL for rhizosphere isolate Br257 and clinical isolate
Br642 (Table S1, Supporting information). The MIC was
determined by broth microdilution as described previ-
ously (Liebens et al. 2014). To exclude the emergence of
antibiotic resistance, MIC values were measured in
triplicate for the different strains after each
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treatment round, and it was checked that there were no
significant correlations between MIC values and treat-
ment round. An increase or decrease in the proportional
representation of one strain relative to the other over
subsequent growth or treatment cycles was tested by
fitting a mixed model on a logit scale and including
cycle as a fixed factor and replicate as a random factor.
This was performed using lme4 in R. Statistical signifi-
cance was assessed using likelihood ratio tests. Analo-
gous control experiments were carried out using pure
cultures of each strain (Fig. S1, Supporting information).
Variation in persistence levels among natural isolates
To determine natural levels of persistence, and to be
able to make a comparison to theoretically expected lev-
els of persistence under plausible antibiotic treatment
frequencies (see Appendix S1, Supporting information),
we measured persistence among 16 environmental and
clinical isolates of P. aeruginosa (Pirnay et al. 2002a;
Table S1, Supporting information). Persister fractions
were measured as the ratio of the number of CFU per
mL obtained after treatment with ofloxacin (Sigma-
Aldrich) relative to the number of CFU per mL
obtained after control treatment with sterile water. Mea-
surements were made by diluting overnight cultures
100-fold in 100 mL of fresh MHB medium and cultur-
ing them for 19 h. Next, stationary phase cultures were
treated for 5 h either with ofloxacin (at 109 the MIC) or
with sterile water. Surviving cells were quantified by
plate counting. Each experiment was performed with at
least three biological replicates. The MIC of each strain
was determined by broth microdilution in triplicate, as
described previously (De Groote et al. 2009). To exclude
the possibility of confounding persistence with antibi-
otic resistance, we tested for a correlation between per-
sistence and the MIC across our strains using Spearman
rank correlation and showed it to be nonsignificant
(Table S1, Supporting information). In addition, we con-
firmed that antibiotic exposure of an isogenic PA14 wt
culture resulted in characteristic biphasic killing,
expected by the fast killing of normal antibiotic-sensi-
tive cells followed by the slow killing of persister cells
(Hofsteenge et al. 2013; Kint et al. 2012; Patra & Klumpp
2013; Fig. S2, Supporting information). Average levels
of persistence per strain were calculated using a bino-
mial mixed model fitted using R package lme4, and 95%
confidence limits on the estimates were calculated using
the effects package. In this model, strain and replicate
were coded as fixed and random factors, respectively.
As a measure of the genetic heritability of persistence
levels, we calculated the repeatability of replicate
measurements of persistence in the same strains based
on the intraclass correlation coefficient (ICC) (Lynch &
Walsh 1998). This ICC and the 95% confidence limits
were calculated on a logit scale using function ICCest
in R package ICC. To provide a reference point of
known historical antibiotic exposure, observed persis-
tence levels of strains from various sampling sites were
compared with the persistence levels documented by
Mulcahy et al. (2010) in P. aeruginosa collected from
patients with cystic fibrosis either before or after
extended ofloxacin treatment schedules. Methodologi-
cally, this data set can be compared to ours, given that
persistence levels were measured using a nearly identi-
cal method (i.e. in stationary phase using an overnight
treatment with ofloxacin and using the same growth
medium). Finally, observed persistence levels were
compared to previously formulated theoretical models
of persisters (Gardner et al. 2007; Kussell et al. 2005,
Appendix S1, Supporting information) to demonstrate
that under plausible antibiotic exposure schedules, the
observed low persistence levels are challenging to
explain without invoking fitness trade-offs with other
growth parameters.
Costs and trade-offs of persistence
To directly measure both direct and indirect, pleiotropic
costs of persistence, we correlated observed levels of per-
sistence with the growth parameters of nine different
strain derived from the Pirnay et al. (2002b) type collec-
tion, as well as those of the PA14 wt and isogenic
CMPG13407 hip high-persister mutant (De Groote et al.
2009). Growth parameters were determined by measuring
OD595 values in liquid culture every 15 min over a period
of 43.25 h using an automated plate reader (Bioscreen C,
Oy Growth Curves Ab, Finland), after which OD values
were converted back to cell numbers (CFU) using an inde-
pendently derived nonlinear calibration curve (given by
the equation Log10(CFU) = 9.066(1.174 + Log10(OD))
0.144,
R2 = 0.9997). Subsequently, a modified Gompertz growth
model (Zwietering et al. 1990) was fitted using Wolfram
Mathematica v9 (code available from the authors on
request), which enabled the simultaneous estimation of
initial cell number, lag time, maximal growth rate and car-
rying capacity. This growth model was chosen on the
basis that it resulted in robust fits with very high explana-
tory power (average R2 = 0.9990, SD = 0.0026, n = 377). In
all cases, samples were first adjusted to near single-cell
level by dilution based on the estimated number of viable
cells present in the sample. Next, single-cell inoculation
was achieved through serial twofold dilution of the
adjusted samples. For each sample, the well with the larg-
est dilution where growth was still observed was consid-
ered to yield a growth curve originating from a single cell
and this growth curve was selected for further analysis.
Growth curves were determined after dilution in fresh
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medium either with or without intermittent treatment
with ofloxacin (cf. section above). To obtain accurate esti-
mates, 15–20 (avg. 17) replicate growth curves were mea-
sured per strain under each condition.
Finally, to measure possible costs of persistence in
terms of affecting cellular mortality and turnover in the
stationary phase, we diluted overnight cultures of each
strain 100-fold in 100 mL of fresh medium and moni-
tored them for 5 days after reaching stationary phase.
During this period, we determined the number of per-
sisters and nonpersisters at 24-h intervals as described
above. Subsequently, we calculated the net rate of
decline of normal and persister cells in stationary phase
cultures as the average decline in the log-transformed
number of normal and persister cells (expressed in CFU)
over time and correlated these with the average propor-
tion of persisters observed in stationary phase in each
strain using Spearman rank correlations. This was per-
formed in triplicate. Net rates of decline were calculated
from the slope of the logarithm of the number of normal
or persister cells as a function of time using linear mixed
models (LMM), in which the three replicates were coded
as a random factor. We should note that this net rate of
decline could be affected by several processes, including
direct mortality, switching between nonpersisters and
persisters as well as direct growth of nonpersister cells
(Patra & Klumpp 2013). However, for our purposes,
which was to document the costs of persistence, the net
rate of decline of normal and persister cells in function
of persistence was a good measure of overall cost, and
hence, it did not matter that this estimate could poten-
tially be affected by several distinct processes.
Results
Low-persister strains have a competitive benefit in the
absence of antibiotic treatment
As expected if persistence is an evolutionarily stable
strategy adapted to a particular frequency of antibiotic
attack (Kussell et al. 2005; Gardner et al. 2007; Patra &
Klumpp 2013), the results of our competition experi-
ments demonstrate that in the absence of antibiotic
treatments, the low-persister strains (wt and Br257)
were more fit than the high-persister strains (hip and
Br642), but that the reverse was true in the presence of
periodic ofloxacin antibiotic treatment (Fig. 1). In fact,
in the absence of antibiotic treatment, five cycles of
dilution and regrowth caused the wt strain to outcom-
pete the hip mutant by a factor of 1.75  0.39
(mean  standard deviation (SD), n = 3) (Fig. 1a, signif-
icance of increase in wt representation after 5 dilution
and growth cycles: LMM on logit-transformed propor-
tions, b = 0.006, v2 = 98.11, P < 1015). Similarly, over
the course of our experiment, the low-persister strain
Br257 outcompeted the high-persister strain Br642 by a
factor of 1.89  0.56 (Fig. 1c, significance of increase in
Br257 representation over 5 dilution and growth cycles:
LMM, b = 0.007, v2 = 52.67, P = 4 9 1013). The large
fitness benefit of the low-persister strains under
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Fig. 1 Relative fitness of high- and low-
persister strains over subsequent growth
cycles in the presence or absence of inter-
mittent antibiotic treatments. Strains with
high and low levels of persister cells (lab-
oratory-adapted hip mutant and PA14 wt,
panels a and b; or the Br642 and Br257
strains, panels c and d) were grown
together in a mixture to stationary phase.
Before each growth cycle, cultures were
exposed to either a control treatment
(panels a and c) or to the antibiotic oflox-
acin (panels b and d). Low-persister
strains took over in the absence of inter-
mittent antibiotic treatments, whereas the
high-persister ones took over if each
growth cycle was preceded by an antibi-
otic treatment. Error bars represent 95%
confidence limits (n = 3 replicates per
treatment combination).
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favourable growth conditions was surprising, given the
expected negligibly small direct growth cost of persis-
tence in the competing high-persister strains, owing to
their overall low fractions of nonreplicating persister
cells (0.002–0.03%). Hence, these results imply the likely
existence of pleiotropically linked costs of persistence.
In the presence of periodic antibiotic treatments, the
reverse pattern could be observed, with 5 cycles of antibi-
otic treatment and regrowth then causing the hip mutant
to outcompete the wt strain by a factor of 31.4  2.5
(Fig. 1b, significance of decrease in hip representation
over five antibiotic treatment cycles: LMM, b = 0.04,
v2 = 190.65, P < 1015) and the high-persister strain
Br642 to outcompete the Br257 strain by a factor of
328  162 (Fig. 1d, significance of increase in Br642 rep-
resentation over five treatment cycles: LMM, b = 0.06,
v2 = 709.24, P < 1015). In control experiments, the cell
numbers (Log10(CFU)) obtained for the hip mutant or wt
after five growth or treatment cycles were not signifi-
cantly different from each other (in the absence of antibi-
otics: paired t-test on logit-transformed proportions:
t = 0.94, P = 0.45, n = 3, in the presence of antibiotic
treatment: t = 2.69, P = 0.15, n = 3, Fig. S1, Supporting
information). Likewise, the numbers of cells obtained
from the Br257 and Br642 strains after 5 dilution and
growth cycles were not significantly different from each
other (paired t-test: t = 2.64, P = 0.12, n = 3), while a mar-
ginal difference in cell numbers was observed over 5 anti-
biotic treatment cycles (t = 5.93, P = 0.03, n = 3, Fig. S1,
Supporting information). This difference, however, was
negligible compared to the difference in representation
seen in the actual competition experiments (Fig. 1d).
Antibiotic resistance did not emerge in any of our compe-
tition assays, as shown by the fact that MIC values
remained unchanged over the course of our experiments
and that we never detected a significant correlation
between MIC and treatment round (Pearson correlations,
all P >> 0.05). In addition, ofloxacin treatment induced a
biphasic killing pattern, characteristic for the presence of
a normal and persister cell subpopulations with differing
antibiotic tolerances (Fig. S2, Supporting information).
Low levels of persistence among natural P. aeruginosa
isolates
Persister fractions in 16 natural strain isolates derived
from the Pirnay et al. (2002) type collection varied by five
orders of magnitude, but were very low, ranging from
3 9 108 to 3 9 104 (Table S1, Supporting information).
Interstrain variation in persistence was highly signifi-
cant (fixed effect ANOVA on logit-transformed propor-
tions of persisters: F17,36 = 76.9, P < 2 9 10
16), and
persistence levels were highly repeatable among
replicate measurements of the same strains (intraclass
correlation 0.96, 95% C.L.: 0.92–0.98). This implies that
variation in persistence levels had a very high genetic
heritability. With a proportion of 7 9 106 persister
cells, the PA14 wt strain was representative for the aver-
age level of persistence observed among the typed
strains, whereas the PA14 hip mutant, with a proportion
of 3 9 104 persister cells, was more similar to natural
isolates with high persistence levels (Table S1, Support-
ing information). Proportions of persisters were highest
among lung and hospital infection isolates, intermediate
in wound, throat or blood infection isolates and lowest
in one environmental isolate (Table S1, Supporting
information). Importantly, persistence levels were not
confounded with antibiotic resistance, as shown by the
nonsignificant correlation between persistence and the
MIC for the antibiotic ofloxacin, used to monitor persis-
tence (Spearman rank R = 0.20, P = 0.42, n = 18).
Comparison of observed persistence levels to those
obtained by Mulcahy et al. (2010) in P. aeruginosa isolated
from cystic fibrosis patients with known historical
records of antibiotic exposure shows that the persistence
levels of our clinical strains were not significantly differ-
ent from the average persistence levels of P. aeruginosa
strains isolated from patients with cystic fibrosis early on
in the infections (1 9 105, n = 15; t-test on Log10-trans-
formed persistence levels, t = 1.16, d.f. = 29, P = 0.25),
but that they were significantly lower than the persis-
tence levels found in the P. aeruginosa strains in those
same patients with CF 6–16 years later, after having been
exposed to extended periods of antibiotic treatment
(2 9 104, n = 15; t = 4.2, d.f. = 29, P = 0.0002) (Fig. 2).
Furthermore, the single environmental isolate had the
second lowest level of persistence of all strains examined
(Fig. 2). Finally, comparison of the observed levels of per-
sistence to values predicted by previously formulated
models (Kussell et al. 2005; Gardner et al. 2007) shows
that the observed low levels of persistence are challeng-
ing to explain without either invoking additional, pleio-
tropically linked costs of persistence aside from a direct
growth cost (Appendix S1, Fig. S3, Supporting informa-
tion), or assuming that also many normal cells would sur-
vive antibiotic attacks (Gardner et al. 2007). Survival of
normal cells, however, was estimated to be very low after
longer durations of antibiotic treatment (Fig. S4, Support-
ing information). Consequently, we decided to test
whether the existence of pleiotropic costs and fitness
trade-offs could be an alternative explanation for the
observed low levels of persistence in P. aeruginosa.
Complex fitness trade-offs explain low levels of
persistence
Theoretical models of persistence dynamics have pro-
posed that a reduction in the population-level growth
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rate in populations with high-persister fractions would
represent the main competitive cost of persistence
under favourable growth conditions (Kussell et al. 2005;
Gardner et al. 2007; Patra & Klumpp 2013). Neverthe-
less, given the observed low levels of persistence in our
study strains (Table S1, Supporting information), this
direct growth cost was expected to be negligibly small.
Indeed, the maximal growth rate did not correlate with
the level of persistence across the strains examined (fol-
lowing dilution only: Pearson R = 0.50, t = 1.72,
d.f. = 9, P = 0.12; following ofloxacin treatment and
dilution: Pearson R = 0.27, t = 0.83, d.f. = 9, P = 0.43;
Fig. S2a,b, Supporting information). The maximal
growth rate of the PA14 wt was slightly higher than
that of the high-persister hip mutant when measured
following dilution in fresh medium (2.058 h1 in the wt
vs. 1.992 h1 in the hip mutant, t = 4.77, d.f. = 167,
P = 4 9 10–6). However, no significant difference was
observed when growth rate was measured following
antibiotic treatment and redilution (1.914 h1 in the wt
vs. 1.902 h1 in the hip mutant, respectively, t = 0.30,
d.f. = 52, P = 0.76). These results suggest that there is
either no or a negligibly small direct growth cost of per-
sistence. In addition, this growth cost would definitely
not be large enough to explain the large competitive
advantage of the low-persister PA14 wild type under
favourable growth conditions (Fig. 1). Persistence levels
also did not show a strong correlation with carrying
capacity (Fig. S2c,d, Supporting information).
In contrast to growth rate or carrying capacity, lag
phase duration was strongly correlated with persis-
tence. In particular, strains with higher persister frac-
tions showed significantly longer lag phases following
redilution in fresh medium in the absence of antibiotic
treatment, reflecting mainly the lag phase duration of
nonpersisters (Fig. 3a, correlation between lag phase
duration and the Log10-transformed proportion of per-
sisters: Pearson R = 0.81, t = 4.11, d.f. = 9, P = 0.003). In
contrast, a reverse correlation was observed when cul-
tures were regrown after antibiotic treatment, reflecting
lag phase duration of persisters. In this case, strains
with higher persister fractions displayed a shorter lag
phase (Fig. 3b, correlation between lag phase duration
and the Log10-transformed proportion of persisters:
Pearson R = 0.84, t = 4.73, d.f. = 9, P = 0.001). These
correlations were not only observed for the set of natu-
ral strains, but also for the PA14 wt and isogenic hip
mutant, with the hip mutant showing a significantly
longer lag phase duration than the wt following redilu-
tion in fresh medium (lag phase durations: 10.993 h in
hip vs. 10.447 h in wt, t = 7.57, d.f. = 167, P = 2 9 1012)
and a reverse pattern following antibiotic treatment (lag
phase durations: 16.476 h in hip vs. 24.583 h in wt,
t = 4.96, d.f. = 56, P = 6 9 106). This suggests that
the observed correlations between lag phase duration
and persistence were not caused by varying selection
pressure in environments characterized by different lev-
els of antibiotic exposure, but instead are directly or
indirectly linked to the persister phenotype. Taken
together, these data imply that in environments with
favourable growth conditions, increased persistence
does not only carry a direct growth cost, but also an
extra cost related to the increased lag phase duration.
The reverse, however, would be true in environments
where periods of growth would be frequently inter-
rupted by stress. Under these conditions, high persis-
tence levels combined with short lag phases would
provide a clear competitive advantage.
Finally, the net rate of cellular decline in stationary
phase showed a positive correlation with persistence lev-
els and therefore represented another previously undoc-
umented cost of persistence (Fig. 4a,b). Surprisingly, this
correlation was seen both for persister cells (Spearman
R = 0.81, d.f. = 9, P = 0.004) as well as for normal cells
(Spearman R = 0.81, d.f. = 9, P = 0.004). This correlation
implies that the more a strain invests in persister cells in
stationary phase, the faster persister cells and normal
cells decline under growth-limiting conditions in the
absence of antibiotics. This conclusion is further sup-
ported by data from the hip mutant, which shows a sig-
nificantly higher rate of decline (0.07 h1, 95% C.L. from
mixed model: 0.06–0.08) compared to the PA14 wt strain
it was derived from (0.04, 95% C.L.: 0.03–0.05).
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Fig. 2 Persistence levels in clinical and environmental isolates
compared to persistence levels in patients with cystic fibrosis.
Persistence levels of 15 clinical strains were comparable to the
average persistence levels of the early cystic fibrosis P. aerugin-
osa isolates of Mulcahy et al. (2010), but lower than the persis-
tence levels found in those same patients with CF 6–16 years
later, after having been exposed to extended periods of antibi-
otic treatment. The single environmental isolate had the second
lowest level of persistence of all strains examined.
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Discussion
Our results provide several lines of evidence that show
that the fraction of antibiotic-tolerant persister cells in
P. aeruginosa is kept at a low level through the existence
of fitness trade-offs with other traits, that is through
antagonistic pleiotropy. Initial support for this hypothe-
sis came from our competition assays, which not only
demonstrated that high-persister strains or mutants
were strongly selected for under environmental regimes
with periodic antibiotic exposure, as had also been
shown in E. coli (Balaban et al. 2004; Stewart & Rozen
2012) and in P. aeruginosa (Mulcahy et al. 2010), but also
that in the absence of antibiotics, the reverse was true,
so that low-persister strains then experienced a large
competitive advantage. This large fitness benefit of
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Fig. 3 Pleiotropic effects of persistence on lag phase duration.
Correlation between lag phase duration and level of persis-
tence upon regrowth, either in the absence (a) or presence of a
prior antibiotic attack (b) (black circles = 9 natural isolates,
open circles: PA14 wt and hip mutant). (a) In the absence of
antibiotic treatment, the lag phase duration upon dilution in
fresh medium is positively correlated with the level of persis-
tence (Pearson R = 0.81, t = 4.11, d.f. = 9, P = 0.003). The same
pattern is seen when the lag phase of the PA14 hip mutant is
compared with that of the wt. Under predominantly favourable
growth conditions, this effect would cause persistence to carry
an additional cost, on top of a small direct growth cost. (b) Fol-
lowing ofloxacin treatment, however, the situation reverses so
that lag phase duration upon dilution in fresh medium is then
negatively correlated with the level of persistence (Pearson
R = 0.84, t = 4.73, d.f. = 9, P = 0.001), and again the same
trend is seen when the lag phase of the PA14 hip mutant is
compared with that of the wt. Error bars indicate 95% confi-
dence limits (n = 3 replicates per treatment combination).
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Fig. 4 Costs of persistence in terms of increased rates of cellu-
lar decline in stationary phase culture. Net rates of cellular
decline in stationary phase of both normal (a) and persister
cells (b) are both positively correlated with persistence levels
and therefore represent another previously undocumented cost
of persistence (Spearman rank correlation of net rate of decline
of persister and normal cells both equal to R = 0.81, d.f. = 9,
P = 0.004) (black circles = 9 natural isolates, open circles: PA14
wt and hip mutant; error bars indicate 95% confidence limits
calculated from the three replicates).
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low-persister strains under favourable growth condi-
tions was surprising, given that the direct growth cost
of persistence in our competing high-persister strains
was expected to be negligibly small, owing to their
overall low fraction of nonreplicating persister cells
(0.002–0.03%, Table S1, Supporting information). Hence,
these experiments clearly suggest the presence of addi-
tional, pleiotropically linked costs of persistence. More
generally, these competitions assays confirm the theo-
retical prediction that higher persistence should be
favoured when antibiotic strikes are frequent, whereas
lower persistence levels should be selected for in envi-
ronments where antibiotic attacks are infrequent or
absent (Gardner et al. 2007; Kussell et al. 2005, Figs S3–
S4, Supporting information).
Aside from the large fitness benefits experienced by
low-persister strains under favourable growth condi-
tions, the very low and repeatable levels of persistence
we documented among natural isolates (3 9 108–
3 9 104, Fig. 2, Table S1, Supporting information) were
also clearly suggestive for the existence of additional,
pleiotropically linked costs of persistence. In fact, accord-
ing to a model in which persistence was assumed to only
carry a direct growth cost (Gardner et al. 2007), we calcu-
lated that observed persistence levels would be stable if
antibiotics struck only once every 200 days for the high-
est persister fractions, or once every 5500 years for the
lowest fractions (Appendix S1, Fig. S3, Supporting infor-
mation), figures that are evidently unrealistic. Previous
studies have also documented levels of persistence in
P. aeruginosa stationary phase cultures that are very low
(Moker et al. 2010; Mulcahy et al. 2010) and many orders
of magnitude lower than in Escherichia coli, Staphylococcus
aureus or Acinetobacter baumannii, where fractions of per-
sisters can sometimes represent 1% or more of the total
population (Barth et al. 2013; reviewed in Lewis 2007,
2010). Despite these low levels of persistence, we found
interstrain variation in the proportion of persisters to be
highly repeatable (intraclass correlation = 0.96), imply-
ing that persistence levels are genetically heritable and
can respond to natural selection. Recently, similarly,
large interstrain variation in persistence has also been
documented in P. aeruginosa (Mulcahy et al. 2010), E. coli
(e.g. Stewart & Rozen 2012; Hofsteenge et al. 2013) and
A. baumannii (Barth et al. 2013).
In a final set of experiments, we found direct sup-
port for the existence of pleiotropically linked costs of
persistence and fitness trade-offs with other growth
parameters. First, we found that in P. aeruginosa,
increased persistence was not correlated with a reduc-
tion in growth rate, unlike what would be expected if
the nonreplication of persister cells represented the
main cost of persistence (Kussell et al. 2005; Gardner
et al. 2007). Second, we found that increased persistence
did strongly correlate with an increased duration of the
lag phase following new colonization without intermit-
tent antibiotic attack (Fig. 3). This implies that, in the
absence of antibiotics, high-persister strains suffer an
additional delay before growth is resumed. Third, there
was a positive correlation between the level of persis-
tence in a given strain and the population-level rate of
cellular decline in stationary phase (Fig. 4). This sug-
gests that populations with a relatively large fraction of
persister cells may suffer increased mortality in
resource-deprived environments. Significantly, both of
these effects were found not only in a comparison of 9
natural strains, but also in the contrasting growth pat-
terns of a high-persister mutant and the wild type from
which it was derived. This suggests that the patterns
we observe are general and are caused by intrinsic,
pleiotropically linked fitness effects as opposed to by
varying selection pressure in environments character-
ized by different levels of antibiotic exposure (which is
known to be capable of affecting lag time, Fridman et al.
2014; and growth rate, e.g. Gilbert et al. 1990). Surpris-
ingly, our results also demonstrated that persistence
and lag phase showed a reverse correlation when cul-
tures were regrown after antibiotic treatment. In that
case, strains with higher persister fractions displayed a
shorter lag phase. Nevertheless, given that following
antibiotic attack, persistence is already expected to be
highly advantageous without any further benefits, and
we expect that the pleiotropic costs, caused by the
lengthening of the lag phase under favourable growth
conditions and the increased mortality under resource-
deprived conditions, are more important and more
strongly affect the evolutionary dynamics of persistence.
A detailed theoretical analysis of the effect of antagonis-
tic pleiotropy on optimal levels of persistence, however,
remains to be performed.
Taken together, our results provide strong support
for the hypothesis that variation in persistence in bacte-
ria is not only shaped by differences in the frequency of
antibiotic exposure, but also by fitness trade-offs with
other growth parameters, including the length of the
lag phase and stationary phase survival. Earlier, tenta-
tive evidence for effects of persistence on lag phase had
also been collected in E. coli, where the high-persister
mutant strain hipA7 was shown to have an extended
lag phase when inoculated into fresh medium (Balaban
et al. 2004; Gefen et al. 2008) and wild-type cultures
displayed extended lag phases when persistence levels
were increased through starvation (Levin-Reisman et al.
2010; Luidalepp et al. 2011). In addition, a similar
lengthening of the lag phase has been observed in the
high-persister mutant shp in Salmonella enterica (Slattery
et al. 2013). This suggests that the trade-off between
increased persistence and a lengthening of the lag phase
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duration may well be a general feature of bacterial per-
sistence. In fact, Geisel et al. (2011) reviewed evidence
that this trade-off may be intrinsic to many bacterial
stress responses and dormancy-type phenomena. On
the other hand, it could be that the magnitude of these
trade-offs would depend on the type of antibiotic the
bacteria are exposed to. For example, beta-lactam antibi-
otics are known to kill only growing cells, whereas flu-
oroquinolones of the type we used also kill nongrowing
cells (Keren et al. 2004), and it might be expected that
this could impact the expression of particular trade-offs.
In addition, there is growing evidence that the tolerance
of persisters may be antibiotic specific in some species,
including E. coli and Acinetobacter baumannii (Luidalepp
et al. 2011; Stewart & Rozen 2012; Barth et al. 2013; Hof-
steenge et al. 2013), and this also appears to be the case
in P. aeruginosa (Pan et al. 2012).
The trade-off between persistence level and cellular
decline in stationary phase that we document has not
been reported before. One explanation for the existence
of this type of antagonistic pleiotropy might be linked
to the fact that in P. aeruginosa and E. coli, increased
persister formation after treatment with fluoroquinolone
antibiotics is increased in strains lacking the stationary
phase sigma factor RpoS (Murakami et al. 2005; Hong
et al. 2012). In gamma-proteobacteria, this same factor is
also essential for stationary phase survival (Potvin et al.
2008; Battesti et al. 2011), explaining the observed nega-
tive correlation. Alternatively, increased mortality in
stationary phase cultures of high-persister strains could
be linked to increased release of the toxin and virulence
factor pyocyanin, which in P. aeruginosa is released at
high densities as a quorum sensing molecule and has
been shown to induce persister formation (Moker et al.
2010). Pyocyanin production, however, is under control
of the Pseudomonas quinolone signal (PQS), which if
highly upregulated can cause partial autolysis (D’Ar-
genio et al. 2002). Indeed, such autolysis is most fre-
quently observed in P. aeruginosa isolates from patients
with chronic cystic fibrosis (D’Argenio et al. 2002),
which are known to display high levels of persistence
(Mulcahy et al. 2010).
Overall, we believe that our results may not only help
explain natural persistence levels, but also boost the
development of more refined mathematical models of
persistence, which could be important to optimize treat-
ment strategies. Persistence levels, for example, could
be kept at a low level by shortening the duration of
antimicrobial therapy in the case of acute infections
(Levin & Rozen 2006), or optimizing the timing of peri-
odically dosed antibiotic treatments in the case of
chronic infections (Fauvart et al. 2011; Cogan et al. 2012,
2013; Cogan 2013; Orman & Brynildsen 2013). Keeping
persistence at a low level in clinical infections is of great
importance, given that persister cells have been shown
to act as a reservoir for the emergence of antibiotic
resistance (Levin & Rozen 2006; Cohen et al. 2013).
Building on the results obtained in this study, we there-
fore believe that important improvements can be made
to existing models of persistence as well as to optimal
treatment schedules of infectious diseases.
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Appendix S1. Evolutionarily stable levels of persistence. 
Derivation of evolutionarily stable levels of persistence 
To assess whether additional costs of persistence, aside from a direct growth cost, are 
required to explain the observed low levels of persistence in P. aeruginosa, we compared 
our empirical estimates of persistence to the values expected by previously published 
evolutionary models of persistence (Gardner et al. 2007; Kussell et al. 2005; Kussell & 
Leibler 2005). These models have consistently found that allocation to non-growing 
persisters or other dormant life stages should be inversely proportional to the duration of 
favorable environmental conditions (Gardner et al. 2007; Kussell et al. 2005; Kussell & 
Leibler 2005; Lachmann & Jablonka 1996; Thattai & van Oudenaarden 2004). Under the 
assumption that bacterial populations are locally founded by small numbers of cells, the 
model of Gardner et al. (2007), for example, predicted that the time-averaged optimal or 
“evolutionarily stable” investment in persister cells    should equal    , where   is the time 
between antibiotic strikes or other environmental catastrophes (Gardner et al. 2007, eqn. 
(1) with     ). The timescale in this model was normalized so that the maximum intrinsic 
rate of growth of non-persister cells and carrying capacity were both equal to 1. To map 
these predictions onto a regular timescale, we substituted   for µ.t where µ.t is the ratio of 
the time to the inflection point in a normal logistic growth curve with maximal growth rate µ 
relative to that in the rescaled logistic growth model of Gardner et al. (2007) and t is the 
time between antibiotic attacks. Further taking into account lag time   as a shift in time, the 
predicted average ESS proportion of persister cells is therefore 
   
 
       
 
eqn. (S1) 
Similarly, Kussell et al. (2005) found that the optimal rate for cells to switch to the 
persister state a is equal to approximately 1/t, where t is the average duration of favorable 
growth conditions (i.e. the time between antibiotic strikes). Since the proportion of persister 
cells during exponential growth is approximately equal to       (Patra & Klumpp 2013), 
this leads to an ESS allocation to persister cells that is identical as in the Gardner et al. 
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(2007) model,        , or   (       ) if we take into account the single-cell lage time   
as a shift in time. In an extended version of his model, Gardner et al. (2004) also 
considered a situation in which some non-persister cells would be able to survive antibiotic 
attacks (eqn. (A.16). This was done by including a parameter s for the survival probability 
of non-persister cells relative to persister cells following an antibiotic attack, which using 
substitutions as above resulted in a somewhat lower ESS proportion of persister cells of 
   
 
       
 
 
   
 
eqn. (S2) 
which is zero when the time between antibiotic attacks t exceeds            .  
 Other limiting cases of the model of Gardner et al. (2007) were not considered, given 
that the predictions above are most realistic with respect to the observed low levels of 
persistence, and including other factors such as kin competition (    ), or increased 
persister cell formation during stationary phase (Gardner et al. 2007; Keren et al. 2004; 
Knudsen et al. 2013; Luidalepp et al. 2011; Patra & Klumpp 2013), would lead to much 
higher ESS persister allocations, which are not consistent with our actual observations. In 
other words, the predictions we considered were evolutionary stable proportions of 
persister cells under average growth conditions, for which our early stationary phase 
culture conditions during which persistence was measured were probably quite 
representative. We should also note that all predictions assume that persister-formation is 
not antibiotic-specific. If it would be (cf. Barth Jr et al. 2013; Hofsteenge et al. 2013; 
Luidalepp et al. 2011; Stewart & Rozen 2012), we would expect a total ESS allocation to 
persisters as given but with subpopulations within the persisters corresponding to the 
probability of each antibiotic being used. At present, little is known, however, about 
whether in P. aeruginosa, persister fractions differ according to the antibiotic that is used. 
In addition, fluoroquinolone antibiotics such as ofloxacin are among the most common 
antibiotics used to treat P. aeruginosa infections (Mulcahy et al. 2010).  
To estimate how long the time between antibiotic strikes would have to be to make the 
observed persistence levels in our P. aeruginosa strains consistent with the predicted ESS 
values, we plotted equations (1) and (2) as a function of the time between antibiotic strikes 
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t (Figs. S3 and S4). For equation (2), parameter s was estimated from a biphasic killing 
curve, obtained by treating the wt strain PA14 with ofloxacin at 10x the MIC and measuring 
the number of surviving cells after 1, 2, 3, 4, 5, 12 and 24h of ofloxaxin exposure using 
plate counting (n=3 replicates) (for details see Figs. S2 and S4). 
 
Comparison of observed and theoretically predicted perister levels 
Based on the basic model of Gardner et al. (2007) (eqn. (S1)), and using our estimates for 
the growth parameters of our study strains, we calculate that a proportion of 10-4 persisters 
would be expected to be the ESS if antibiotics were encountered every ca. 200 days, 
whereas the lowest levels of persistence of 10-8 would be the ESS if antibiotics struck only 
every ca. 5500 year (Fig. S3). These estimates are clearly highly unrealistic, as the high-
persister strains are typically derived from chronic infections in hospital environments that 
would be exposed to intensive antibiotic treatment schedules, and that many of the low-
persister strains were also derived from clinical environments. If a small fraction of non-
persister cells would be able to survive antibiotic attack (eqn. (S2)), predictions become 
slightly more realistic in that very low levels of persistence could also become 
evolutionarily stable under a narrow parameter range (Fig. S4). Whether antibiotic 
tolerance of normal, replicating cells could explain the observed low levels of persistence, 
however, critically depends on the average length of each round of antibiotic exposure. 
From a biphasic killing curve, characteristic for the fast killing of normal cells followed by 
the slower killing of persister cells (Fig. S2), we estimate that if an average antibiotic 
treatment episode lasted longer than ca. 10 hours, so few normal cells would survive that 
predictions would approach those of the basic model (Fig. S4). In addition, even with 
shorter treatment times, where some normal cells could still survive, predicted persistence 
levels in the extended ESS model are either much higher (for short periods between 
antibiotic attacks) or lower (zero, for long periods between antibiotic attacks) than 
observed (Fig. S3). From this, we conclude that the observed low levels of persistence are 
challenging to explain based on existing models, thereby prompting us to investigate 
possible pleiotropic costs of persistence on other growth parameters.  
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Supplementary Table S1. Persistence levels as a function of strain origin among natural isolates of P. aeruginosa. 
Observed proportions of persister cells in stationary phase cultures varied by 5 orders of magnitude among 16 natural 
isolates, and were highest among lung and hospital infections, intermediate in wound, throat or blood infections and lowest 
in one environmental isolate. Persistence levels were not confounded with antibiotic resistance, as shown by the 
nonsignificant correlation between persistence and the minimum inhibitory concentration (MIC) for the antibiotic ofloxacin, 
used to monitor persistence (Spearman rank R=0.20, p=0.42, n=18). 
Strain Geographical origin Sampling site Reference Mean prop. 
of persister 
cells 
95 % confidence 
limits (n = 3) 
MICofloxacin 
(µg/ml) 
Bu004 Budapest (Hungary) Throat Pirnay et al. 2002 3.E-08 2.E-08 5.E-08 0.625 
Br257 Brussels (Belgium) Plant rhizosphere Pirnay et al. 2002 1.E-07 7.E-08 2.E-07 1.25 
Br735 Brussels (Belgium) Burn wound Pirnay et al. 2002 2.E-07 2.E-07 4.E-07 0.625 
Mi162 Michigan (USA) Burn wound Pirnay et al. 2002 4.E-07 3.E-07 7.E-07 10 
Mi159 Michigan (USA) Pressure sore Pirnay et al. 2002 2.E-06 1.E-06 3.E-06 1.25 
Ro124 Rotterdam (The Netherlands) Burn wound Pirnay et al. 2002 3.E-06 2.E-06 5.E-06 2.5 
Bo546 Boston (USA) Burn wound Pirnay et al. 2002 4.E-06 3.E-06 6.E-06 2.5 
PAO1 Krylov Melbourne (Australia) Wound Pirnay et al. 2002 5.E-06 3.E-06 8.E-06 1.25 
PA14 wt Wild type lab strain Burn wound De Groote et al. 2009 7.E-06 5.E-06 1.E-05 0.2 
ATCC 27853 Boston (USA) Blood Pirnay et al. 2002 1.E-05 7.E-06 2.E-05 10 
Br680 Brussels (Belgium) Burn wound Pirnay et al. 2002 1.E-05 8.E-06 2.E-05 0.625 
Br642 Brussels (Belgium) Hospital environment Pirnay et al. 2002 2.E-05 1.E-05 3.E-05 2.5 
PAO1 Pirnay Melbourne (Australia) Wound Pirnay et al. 2002 2.E-05 1.E-05 3.E-05 1.25 
Be128 Beverwijk (The Netherlands) Bronchus Pirnay et al. 2002 3.E-05 2.E-05 4.E-05 1.25 
Bo548 Boston (USA) Burn wound Pirnay et al. 2002 3.E-05 2.E-05 4.E-05 2.5 
Be136 Beverwijk (The Netherlands) Bronchus Pirnay et al. 2002 5.E-05 3.E-05 7.E-05 2.5 
PA14 hip Mutant lab strain  De Groote et al. 2009 0.0003 0.0002 0.0005 0.4 
Aa249 Aachen (Germany) Burn wound Pirnay et al. 2002 0.0003 0.0002 0.0005 40 
 
 
       
5 
 
Supplementary Figures 
 
Figure S1. Control experiments for competition assays with single strains 
in pure cultures. Strains were grown until stationary phase and treated with 
either sterile water (a, c) or ofloxacin (b, d) before being diluted in fresh medium. 
Data shown in panels (a) and (b) represent results for the PA14 laboratory 
strains (wt and hip mutant), whereas panels (c) and (d) show results for clinical 
isolates Br257 and Br642. At each stage, the number of CFU was determined by 
plate counting. Data points show the values before treatment. Error bars 
represent 95 % confidence limits calculated from the 3 replicates.  
 
Figure S2. Biphasic killing curve of the total bacterial population after 
exposure to antibiotics. As expected when a subpopulation of antibiotic-
tolerant perister cells are present, an isogenic wt culture shows distinctly biphasic 
killing dynamics following treatment with the antibiotic ofloxacin (at 10x the MIC), 
corresponding with a fast decay of normal, antibiotic-sensitive cells and a slow 
decay of antibiotic-tolerant persisters (Kint et al. 2012; Patra & Klumpp 2013). 
Data points and error bars are means and 95% confidence limits of 3 replicates. 
The fitted curve represents the nonlinear best-fit biphasic killing curve, which was 
fitted to the Log10 transformed numbers of cells (CFU/ml) based on the equation 
Log10(CFU)=Log10((N(0)-P(0)).Exp(-kn.)+P(0).Exp(-kp.)), where  was treatment 
time (in hours), N(0) and P(0) were the number of normal and persister cells at 
treatment time 0 and kn and kp were the rate at which normal and persister cells 
were killed (per hour). The best-fit curve is shown for the best fit parameters 
N(0)= 84055552, P(0)= 20232, kn=1.54 (h
-1) and kp=0.023 (h
-1).  
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Figure S3. Expected evolutionarily stable proportion of persister cells as a 
function of the duration between antibiotics attack. Based on the model of 
Gardner et al. (2007) (eqn. (S1)), the evolutionarily stable (ESS) proportions of 
persister cells are plotted as a function of the duration between antibiotic attacks 
for the average growth parameters as measured in our P. aeruginosa study 
strains (average maximal growth rate   = 0.0345 min-1 = 49.68 day-1 and lag 
phase duration   = 517 mins, minimum value, dotted curve; 911 mins, average 
value, dashed curve; 1923 mins, maximum value, full curve). The influence of the 
observed variation in growth rate across strains was very small and therefore not 
shown. Predictions are shown for the case where persistence levels do not 
facultatively respond to local environmental conditions and bacterial populations 
are locally founded by small numbers of cells (    ). 
 
Figure S4. Expected evolutionarily stable proportion of persister cells as a 
function of the duration between antibiotics attack if some non-persister 
cells survive antibiotic attacks. Based on the extended model of Gardner et al. 
(2007) (eqn. (2)), the evolutionarily stable (ESS) proportions of persister cells are 
plotted as a function of the duration between antibiotic attacks and the survival 
probability of non-persister relative to persister cells s for the average growth 
parameters as measured in our P. aeruginosa study strains (average maximal 
growth rate   = 0.0345 min-1 = 49.68 day-1 and average lag phase duration   = 
911 mins) and with s=0.00052 (dotted line), 5.5 x 10-6 (dashed line) or 1.3 x 10-8 
(full line), corresponding to a situation where antibiotic attacks would last for an 
average of 5h (the treatment duration using in our competition experiments), 8h 
or 12h (given that s=Exp(-kn.)/Exp(-kp. and with best-fit parameters given in Fig. 
S1). 
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Figure S5. Persistence does not significantly affect the maximal growth 
rate and is not pleiotropically linked to carrying capacity. The maximal 
growth rate (h-1) does not correlate with the level of persistence across the 9 
natural isolates (following dilution only, (a): Pearson R = -0.50, t = -1.72, df = 9, p 
= 0.12; following ofloxacin treatment and dilution, (b): Pearson R = 0.27, t = 0.83, 
df = 9, p = 0.43). Similarly, persistence also does not or only very weakly 
correlate with the carrying capacity reached in stationary-phase cultures 
(following dilution only, (c): Pearson R = -0.04, t = -0.14, df = 9, p = 0.89; 
following ofloxacin treatment and dilution, (d): Pearson R = 0.61, t = 2.32, df = 9, 
p = 0.04), and no differences were observed in the carrying capacity reached by 
the PA14 wt and isogenic hip mutant (t-tests, p > 0.05). 
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Figure S1 
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Figure S2 
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Figure S3 
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Figure S4 
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Figure S5 
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